Literature DB >> 24189930

Prostate cancer: Non-O blood type is VTE risk factor after radical prostatectomy.

Melanie Clyne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24189930     DOI： 10.1038/nrurol.2013.255

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy.

Authors:  Matthew K Tollefson; R Jeffrey Karnes; Laureano Rangel; Rachel Carlson; Stephen A Boorjian
Journal:  J Urol       Date:  2013-10-17       Impact factor: 7.450
  1 in total
  3 in total

1.  ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity.

Authors:  Donatas Stakišaitis; Milda Juknevičienė; Albertas Ulys; Dalia Žaliūnienė; Daiva Stanislovaitienė; Ramunė Šepetienė; Anželika Slavinska; Kęstutis Sužiedėlis; Vita Lesauskaitė
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

2.  AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy.

Authors:  Su Jung Oh; Philipp Mandel; Felix K H Chun; Pierre Tennstedt; Sven Peine; Jan Lukas Hohenhorst; Jens Hiller; Markus Graefen; Derya Tilki; Thomas Steuber
Journal:  Front Surg       Date:  2017-12-18

Review 3.  Role of von Willebrand factor in venous thromboembolic disease.

Authors:  Alison Michels; David Lillicrap; Michael Yacob
Journal:  JVS Vasc Sci       Date:  2021-10-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.